Get started
COCHLEAR LIMITEDCOCHLEAR LIMITEDCOCHLEAR LIMITED

COCHLEAR LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

COH chart


Full chart

COH upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪18.91 B‬ AUD
Dividend yield (indicated)
1.86%
Price to earnings Ratio (TTM)
53.62
Basic EPS (TTM)
5.44 AUD
Net income (FY)
‪356.80 M‬ AUD
Revenue (FY)
‪2.26 B‬ AUD
Shares float
‪61.73 M‬
Beta (1Y)
0.21

Employees


Employees (FY)
‪5 K‬
Change (1Y)
+200 +4.17%
Revenue / Employee (1Y)
‪451.64 K‬ AUD
Net income / Employee (1Y)
‪71.36 K‬ AUD

About COCHLEAR LIMITED


Sector
Health Technology
Industry
Medical Specialties
CEO
Diggory William Howitt
Website
cochlear.com
Headquarters
Sydney
Founded
1983
ISIN
AU000000COH5
FIGI
BBG000FT0N80
Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Cochlear Implants, Services, and Acoustics. The Cochlear Implants segment deals with the treatment pathway for acquired or progressive hearing loss. The Services segment offers sound processor upgrades, accessories, and others. The Acoustic segment is for the bone conduction systems. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

COH news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of COH is 289.08 AUD — it has decreased by −0.70% in the past 24 hours. Watch COCHLEAR LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange COCHLEAR LIMITED stocks are traded under the ticker COH.
COH stock has risen by 0.12% compared to the previous week, the month change is a −3.57% fall, over the last year COCHLEAR LIMITED has showed a −3.07% decrease.
We've gathered analysts' opinions on COCHLEAR LIMITED future price: according to them, COH price has a max estimate of 332.00 AUD and a min estimate of 262.22 AUD. Watch COH chart and read a more detailed COCHLEAR LIMITED stock forecast: see what analysts think of COCHLEAR LIMITED and suggest that you do with its stocks.
COH reached its all-time high on Jul 26, 2024 with the price of 350.31 AUD, and its all-time low was 2.68 AUD and was reached on Dec 4, 1995. View more price dynamics on COH chart.
See other stocks reaching their highest and lowest prices.
COH stock is 1.30% volatile and has beta coefficient of 0.21. Track COCHLEAR LIMITED stock price on the chart and check out the list of the most volatile stocks — is COCHLEAR LIMITED there?
Today COCHLEAR LIMITED has the market capitalization of ‪18.87 B‬, it has increased by 1.65% over the last week.
Yes, you can track COCHLEAR LIMITED financials in yearly and quarterly reports right on TradingView.
COCHLEAR LIMITED is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
COH earnings for the last half-year are 2.96 AUD per share, whereas the estimation was 3.11 AUD, resulting in a −4.56% surprise. The estimated earnings for the next half-year are 2.88 AUD per share. See more details about COCHLEAR LIMITED earnings.
COCHLEAR LIMITED revenue for the last half-year amounts to ‪1.14 B‬ AUD, despite the estimated figure of ‪1.18 B‬ AUD. In the next half-year revenue is expected to reach ‪1.17 B‬ AUD.
COH net income for the last half-year is ‪165.40 M‬ AUD, while the previous report showed ‪191.40 M‬ AUD of net income which accounts for −13.58% change. Track more COCHLEAR LIMITED financial stats to get the full picture.
COCHLEAR LIMITED dividend yield was 1.23% in 2024, and payout ratio reached 75.31%. The year before the numbers were 1.44% and 72.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪5.00 K‬ employees. See our rating of the largest employees — is COCHLEAR LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COCHLEAR LIMITED EBITDA is ‪606.40 M‬ AUD, and current EBITDA margin is 26.85%. See more stats in COCHLEAR LIMITED financial statements.
Like other stocks, COH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COCHLEAR LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COCHLEAR LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COCHLEAR LIMITED stock shows the buy signal. See more of COCHLEAR LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.